Floatz logo

Letrozole

Beta Thalassemia Major Anemia

Cairo UniversitySmall moleculePhase 4 / ApprovedDormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Beta Thalassemia Major Anemia cohort.

Asset / SponsorPhaseRating
Metformin
Bahria University
Phase 4BB
Petadeferitrin
Pharmacosmos A/S
Phase 2CC
Alpha Tocopherol
Indonesia University
N/AD

Same molecule, other indications

Letrozole is also rated in:

infertility disorderDormant
BBB
Indicative ·
79 / 100
View asset →
anovulationDormant
BBB
Indicative ·
78 / 100
View asset →
Diabetes MellitusDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →